STAT

Opinion: Machine learning for clinical decision-making: pay attention to what you don’t see

Don't take results from machine learning algorithms at face value. Ask what information isn't available. What subgroups haven't been prioritized? Who is on the research team?

Even as machine learning and artificial intelligence are drawing substantial attention in health care, overzealousness for these technologies has created an environment in which other critical aspects of the research are often overlooked.

There’s no question that the increasing availability of large data sources and off-the-shelf machine learning tools offer tremendous resources to researchers. Yet a lack of understanding about the limitations of both the data and the algorithms can lead to erroneous or unsupported conclusions.

Given that machine learning in the health domain can have a direct impact on people’s lives, broad claims emerging from this kind of research should not be embraced in the data and analyses.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT1 min read
STAT+: Nuclear Regulatory Commission Advisers Beset By Conflicts Of Interest, Report Finds
Advisers to the Nuclear Regulatory Commission, a U.S. government agency tasked with ensuring the safe use of radioactive materials, were beset by conflicts of interest, report finds

Related